Brazil

Brazil: Wind Power Now Cheaper Than Natural Gas

- Adam Clare 1 Comment

In Brazil a recent energy auction has shown that wind power is cheaper than natural gas in the country, and also a better investment opportunity. The competitiveness of sustainable energy sources continues to impress everyone (even with the subsidized resource-extraction industries), it’s only a matter of time until other sustainable energy options get this cheap.

They even expect the cost of wind power to decrease in the coming years!

EPE president and chief executive Mauricio Tolmasquim said the auctions show that wind and natural gas are competitive, predicting wind prices will continue to fall in Brazil.

“That wind power plants have been contracted at two digit prices, below 100 reals per MWh, showcases the energy market competition through auctions,” he said. “That wind power could reach these lows versus natural gas was unimaginable until recently.”

The energy auctions for a total of 92 projects were the first in Brazil for 2011, and also featured biomass, hydro-electric and natural gas projects.

Investments amounted to 11.2bn reals in total, for 3,962MW of energy that is slated to start generating in 2014.

Read more at Business Green.

HIV/AIDS Drug Patent Revoked

- Adam Clare 8 Comments

Doctors WIthout Borders has released a press release that says that an HIV/AIDS drug can now be made generically. This will lower the cost of the drug allowing more people access to it, this is very important for people living in the developing world. The company that held the patent, Gilead Sciences, claimed to have invented the drug tenofovir disoproxil fumarate (TDF), which has been discredited based on prior art.

In India, the Indian Network for People Living with HIV/AIDS opposed Gilead’s patent application in May 2006 on similar grounds to PUBPAT’s challenge in the US. The evidence on which the US based its decision could therefore lead to the Indian patent office rejecting the patent application. Similarly, in Brazil, a patent opposition filed by HIV/AIDS groups and a government pharmaceutical laboratory could also mean a patent might not be granted for TDF in Brazil.

If a patent is not granted in these countries, generic manufacturers could freely manufacture and export generic versions of TDF without restrictions, leading to greater competition and therefore lower prices.

Brazil and India Defend Nature

- Adam Clare 1 Comment

Last year India saw that biopiracy was damaging to the country and they reacted by documenting every plant and will release an encyclopedia of all the plants. They are specifically recording how these plants are used in traditional medicine in India, making it much harder for large foreign corporations to proclaim the use of plants as their idea.

Brazil is now doing something similar:

“Brazil has published a list of more than 5,000 generic terms from the Portuguese language related to Brazilian plant biological diversity to raise awareness and prevent further misuse of trademarks that hinder Brazilian exports.

The Brazilian government has been, and is, involved in a number of trademark disputes with companies that, for example, take a name of a fruit in Brazilian Portuguese and trademark it to get exclusive rights to commercialise it under that name in a certain country or region.”

Scroll To Top